Search Results - "Bierman, Wouter F W"

Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study by Hensley, Kathryn S, Jongkees, Marlou J, Geers, Daryl, GeurtsvanKessel, Corine H, Mueller, Yvonne M, Dalm, Virgil A S H, Papageorgiou, Grigorios, Steggink, Hanka, Gorska, Alicja, Bogers, Susanne, den Hollander, Jan G, Bierman, Wouter F W, Gelinck, Luc B S, Schippers, Emile F, Ammerlaan, Heidi S M, van der Valk, Marc, van Vonderen, Marit G A, Delsing, Corine E, Gisolf, Elisabeth H, Bruns, Anke H W, Lauw, Fanny N, Berrevoets, Marvin A H, Sigaloff, Kim C E, Soetekouw, Robert, Branger, Judith, de Mast, Quirijn, Lammers, Adriana J J, Lowe, Selwyn H, de Vries, Rory D, Katsikis, Peter D, Rijnders, Bart J A, Brinkman, Kees, Roukens, Anna H E, Rokx, Casper

“…Vaccines can be less immunogenic in people living with HIV (PLWH), but for SARS-CoV-2 vaccinations this is unknown. In this study we set out to investigate,…”
Get full text

Psychological distress among frontline workers during the COVID-19 pandemic: A mixed-methods study by van der Goot, Wieke E, Duvivier, Robbert J, Van Yperen, Nico W, de Carvalho-Filho, Marco A, Noot, Kirsten E, Ikink, Renee, Gans, Rijk O. B, Kloeze, Eveline, Tulleken, Jaap E, Lammers, A. J. Jolanda, Jaarsma, A. Debbie C, Bierman, Wouter F. W

“…Background Novel virus outbreaks, such as the COVID-19 pandemic, may increase psychological distress among frontline workers. Psychological distress may lead…”
Get full text

HIV monotherapy with ritonavir-boosted protease inhibitors : a systematic review by BIERMAN, Wouter F. W, VAN AGTMAEL, Michiel A, NIJHUIS, Monique, DANNER, Sven A, BOUCHER, Charles A. B

“…To assess the efficacy of ritonavir-boosted protease inhibitor monotherapy. Systematic review of all protease inhibitor-monotherapy studies published in…”
Get full text

Yield of yearly routine physical examination in HIV-1 infected patients is limited: A retrospective cohort study in the Netherlands by van Amsterdam, Marleen A, van Assen, Sander, Sprenger, Herman G, Wilting, Kasper R, Stienstra, Ymkje, Bierman, Wouter F W

“…Routine physical examinations might be of value in HIV-infected patients, but the yield is unknown. We determined the diagnoses that would have been missed…”
Get full text

Protease inhibitors atazanavir, lopinavir and ritonavir are potent blockers, but poor substrates, of ABC transporters in a broad panel of ABC transporter-overexpressing cell lines by Bierman, Wouter F. W., Scheffer, George L., Schoonderwoerd, Antoinet, Jansen, Gerrit, van Agtmael, Michiel A., Danner, Sven A., Scheper, Rik J.

“…Objectives A possible mechanism for HIV therapy failure is the efflux of HIV drugs from viral target cells or certain body compartments by ATP-binding cassette…”
Get full text

Treatment outcome of intravenous artesunate in patients with severe malaria in the Netherlands and Belgium by Kreeftmeijer-Vegter, Annemarie R, van Genderen, Perry J, Visser, Leo G, Bierman, Wouter F W, Clerinx, Jan, van Veldhuizen, Cees K W, de Vries, Peter J

“…Intravenous (IV) artesunate is the treatment of choice for severe malaria. In Europe, however, no GMP-manufactured product is available and treatment data in…”
Get full text

Periodontal inflammation as a potential driver of HIV low level viremia by Stam, Arjen J, Groenewegen, Hester, Vissink, Arjan, Wensing, Annemarie M J, Nijhuis, Monique, Bierman, Wouter F W

“…HIV can be successfully suppressed to undetectable levels by antiretroviral therapy (ART) in most people with HIV (PWH). However, a small proportion continues…”
Get full text

Failure of Treatment with First-Line Lopinavir Boosted with Ritonavir Can Be Explained by Novel Resistance Pathways with Protease Mutation 76V by Nijhuis, Monique, Wensing, Annemarie M. J., Bierman, Wouter F. W., de Jong, Dorien, Kagan, Ron, Fun, Axel, Jaspers, Christian A. J. J., Schurink, Karin A. M., van Agtmael, Michael A., Boucher, Charles A. B.

“…BackgroundVirological failure of first-line antiretroviral therapy based on lopinavir boosted with ritonavir (lopinavir/r) has rarely been associated with…”
Get full text

Immune markers and microbial factors are related with periodontitis severity in people with HIV by Groenewegen, Hester, Delli, Konstantina, Vissink, Arjan, Spijkervet, Frederik K. L., Bierman, Wouter F. W.

“…Objective The objective of the study is to assess systemic immune markers and microbial factors related to periodontitis severity in people living with HIV…”
Get full text

Dynamics of Low-Level Viremia and Immune Activation after Switching to a Darunavir-Based Regimen by Stam, Arjen J, Buchholtz, Ninée V E J, Bierman, Wouter F W, van Crevel, Reinout, Hoepelman, Andy I M, Claassen, Mark A A, Ammerlaan, Heidi S M, van Welzen, Berend J, van Kasteren, Marjo E E, van Lelyveld, Steven F L, de Jong, Dorien, Tesselaar, Kiki, van Luin, Matthijs, Nijhuis, Monique, Wensing, Annemarie M J, Lowerit Study Team

“…There is an ongoing debate regarding whether low-level viremia (LLV), in particular persistent LLV, during HIV treatment with optimal adherence originates from…”
Get full text

Evolution and viral characteristics of a long-term circulating resistant HIV-1 strain in a cluster of treatment-naive patients by Hofstra, L Marije, Nijhuis, Monique, Pingen, Marieke, Mudrikova, Tania, Riezebos-Brilman, Annelies, Simoons-Smit, Alberdina M, Van Ham, Petra M, Bierman, Wouter F W, Wensing, Annemarie M J

“…Transmitted resistant HIV may revert to wild-type in the absence of drug pressure due to reduced replication capacity (RC). We observed eight therapy-naive…”
Get full text

Quality Assessment of Internet Information Regarding Periodontitis in Persons Living with HIV by Groenewegen, Hester, Vissink, Arjan, Spijkervet, Fred K L, Bierman, Wouter F W, Delli, Konstantina

“…The Internet is the most used source of HIV information second to information received from healthcare professionals. The aim of this study was to assess the…”
Get full text

Severe periodontitis is more common in HIV- infected patients by Groenewegen, Hester, Bierman, Wouter F.W., Delli, Konstantina, Dijkstra, Pieter U., Nesse, Willem, Vissink, Arjan, Spijkervet, Frederik K.L.

“…•Severe periodontitis is more common in HIV- infected patients.•Particularly older males ran a higher risk for severe periodontitis.•Immunological/virologic…”
Get full text

Urine as Sample Type for Molecular Diagnosis of Natural Yellow Fever Virus Infections by Reusken, Chantal B E M, Knoester, Marjolein, GeurtsvanKessel, Corine, Koopmans, Marion, Knapen, Daan G, Bierman, Wouter F W, Pas, Suzan

Get full text

Immunogenicity of an Additional mRNA-1273 SARS-CoV-2 Vaccination in People With HIV With Hyporesponse After Primary Vaccination by Jongkees, Marlou J, Geers, Daryl, Hensley, Kathryn S, Huisman, Wesley, GeurtsvanKessel, Corine H, Bogers, Susanne, Gommers, Lennert, Papageorgiou, Grigorios, Jochems, Simon P, den Hollander, Jan G, Schippers, Emile F, Ammerlaan, Heidi S M, Bierman, Wouter F W, van der Valk, Marc, Berrevoets, Marvin A H, Soetekouw, Robert, Langebeek, Nienke, Bruns, Anke H W, Leyten, Eliane M S, Sigaloff, Kim C E, van Vonderen, Marit G A, Delsing, Corine E, Branger, Judith, Katsikis, Peter D, Mueller, Yvonne M, de Vries, Rory D, Rijnders, Bart J A, Brinkman, Kees, Rokx, Casper, Roukens, Anna H E

“…Abstract Background The COVIH study is a prospective coronavirus disease 2019 (COVID-19) vaccination study in 1154 people with HIV (PWH), of whom 14% showed…”
Get full text

Association of periodontitis with markers of immunologic and haemostatic state in people living with HIV by Groenewegen, Hester, Borjas-Howard, Jaime F., Delli, Konstantina, Meijer, Karina, Vissink, Arjan, Spijkervet, Frederik K.L., Lambeck, Annechien J.A., Bierman, Wouter F.W.

Get full text

Relevance of the drug–drug interactions between lidocaine and the pharmacokinetic enhancers ritonavir and cobicistat by Dekkers, Bart G.J, Bierman, Wouter F.W, Touw, Daan J, Alffenaar, Jan-Willem C

Get full text

Vaccination with Fendrix of prior nonresponding patients with HIV has a high success rate by Machiels, Julian D, Braam, Esmée E, van Bentum, Petra, van Vugt, Michèle, de Vries-Sluijs, Theodora E.M.S, Schouten, Ineke W.E.M, Bierman, Wouter F.W, Gisolf, Elisabeth H

“…BACKGROUND:Patients with HIV have a poor serological conversion rate with the standard vaccination strategy against hepatitis B virus (HBV) of around 50%…”
Get full text

Risk factors contributing to a low darunavir plasma concentration by Daskapan, Alper, Stienstra, Ymkje, Kosterink, Jos G. W., Bierman, Wouter F. W., Werf, Tjip S., Touw, Daan J., Alffenaar, Jan‐Willem C.

“…Darunavir is an efficacious drug; however, pharmacokinetic variability has been reported. The objective of this study was to find predisposing factors for low…”
Get full text

Darunavir Population Pharmacokinetic Model Based on HIV Outpatient Data by Daskapan, Alper, Tran, Quynh T D, Cattaneo, Dario, Gervasoni, Cristina, Resnati, Chiara, Stienstra, Ymkje, Bierman, Wouter F W, Kosterink, Jos G W, van der Werf, Tjip S, Proost, Johannes H, Alffenaar, Jan-Willem C, Touw, Daniel J

“…Darunavir is a second-generation protease inhibitor and is registered for the treatment of HIV-1 infection. The aim of this study was to develop and validate a…”
Get full text